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Introduction. Coronary heart disease (CHD) ranks first among mortality causes 
in the world over the years [1]. Present scientific studies prove the leading role of 
chronic systemic inflammation (CSI) in the onset and progression of atherosclerosis 
(ASVD), which has been the morphological basis of CHD [2, 3]. Taking into account 
the above-mentioned, it is relevant to study the interaction of components of the 
pathogenetic process in the ASVD and CHD, the factors of formation and 
progression of the specified pathology in order to determine the diagnostic markers 
for the development and destabilization of these diseases and developing rational 
therapeutic approaches. 
The purpose of our research was to study the relationship between the 
indicators of systemic inflammation, the lipid spectrum of blood and the structural 
and functional condition of the heart in patients with stable CHD, and the search for 
predictors of its progression. 
Materials and methods. One-time, open-label, single group clinical trial 
involved 115 patients with CHD: stable angina pectoris, FC II, НF 0-І (62 men and 
53 women aged 54±6.2). 
Patients were given laboratory and instrumental studies. The levels of total 
cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein 
cholesterol (HDL), triglycerides (TG) by sedimentation, fibrinogen (Fg) 
concentration in blood by gravimetric analysis, the level of cytokines (CK) in the 
blood (interleukin 1β (IL-1β), tumor necrosis factor (TNFα), interleukin 10 (IL-10)) 
by the immune enzyme method, the content of circulating endothelial microparticles 
(EMP) of CD32
+
CD40
+
 in blood by cytofluorometry, mRNA gene expression of 
kappa B-alpha inhibitor (IkBα) of the nuclear kappa B transcription factor (NF-kB) in 
mononuclear cells of the peripheral blood by real-time polymerase chain reaction 
(Real-time PCR) were being determined [4, 5, 6]. Echocardiography and the 24 hour 
Holter ECG monitoring were performed by the standard method. A correlation and 
regression analysis was conducted. 
Results. Moderate direct correlation between IL-1β level and blood lipid 
spectrum indicators, TNFα levels and LDL cholesterol levels has been detected. 
Fibrinogen (Fg) concentration was positively correlated with all investigated blood 
lipid spectrum indicators, as well as TNFα, IL-1β and IL-10 levels. Also, a direct 
moderate correlation between the amount of IL-1β and EMP CD32+ CD40+, which 
characterizes inflammatory activation and endothelial dysfunction, was determined. 
The level of mRNA IkB expression positively correlated with the the level of 
cytokines, total cholesterol and LDL cholesterol in a moderate way. 
Investigation of the ratio of central hemodynamics indices and CSI markers 
revealed inverse correlation between left ventricular (LV) ejection fraction (EF) and 
TNFα (r=-0.340, p<0.05), LVEF and Fg (r=-0.336, p<0.01), direct correlation 
between LV isovolumetric relaxation time (IVRT) and EMP CD32
+
CD40
+
  (r=0.311, 
p<0.05), DT and EMP CD32
+
CD40
+
 (r=0.383, p<0.01), as well as inverse ones — 
between the ratio of the phases of the transmitral flow (E/A) and IL-1β (r=0.333, 
p<0.05). 
Analysis of the correlation between Holter ECG indicators and inflammatory 
markers revealed a direct moderate correlation between total ischemic burden (ΣtST 
depr), and TNFα and Fg, the same association was found in relation to the number of 
episodes of depression in the ST segment. 
To determine the independent predictors of cardiovascular risk regression 
analysis has been conducted. The values of TNFα and Fg were found to be prognostic 
markers affecting LVEF, proving the role of CSI in the development of LV systolic 
dysfunction: LVEF=60.74–0.33* TNFα–1.32*Fg. 
For the E/A parameter of the transmitral flow, the linear regression equation has 
had the form: Е/А=0.96–0.02*IL-1β, for deceleration time (DT) — 
DT=199.17+3.72*EMP CD32
+
CD40
+
. The linear regression equation has also been 
obtained: IVRT=87.44+1.04*EMP CD32
+
CD40
+
. The indicated regression models 
prove the association of CSI markers and inflammatory endothelial activation with 
the development and progression of LV diastolic dysfunction 
Myocardial ischemia prognosis has been presumable by CSI markers — TNFα 
and Fg: ΣtST depr =23.01+1.13* TNFα–4.58* Fg. 
Conclusion. Thus, we have identified the central role of CSI in the pathogenesis 
of CHD, the relationship between CSI and dyslipidemia, endothelial dysfunction and 
coagulation potential of blood. According to the results of the correlation and 
regression analysis, it has been found out that CSI negatively affects the systolic 
function of LV and the components characterizing the diastolic function of LV 
(IVRT, DT, E/A), it has influence on the development of ischemic changes and 
electrical myocardial instability. 
Prospects for further research. The data obtained are the basis for an active 
study of the efficiency of anti-inflammatory agents in patients with CHD in order to 
develop new pathogenetically based therapeutic approaches. 
Recommendations. It is relevant to introduce actively into the clinical practice 
the use of certain predictors of myocardial ischemia and central hemodynamic 
disorders in order to stratify cardiovascular risk in patients with CHD. 
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